I chose this topic because I considered it essential to assess the potential of 3T multicontrast cortical lesion detection protocols. Cortical lesions represent a large percentage of the overall lesion load in multiple sclerosis. Unfortunately, they are more difficult to detect in clinical standard 1.5T and 3T MRI scans. 7T scanners have given very promising results in detecting cortical lesions, but these scanners are not widely available, so the majority of people with multiple sclerosis will not be assessed using 7T scanners in the near future.
Fortunately, current image processing tools allow the accurate coregistration of multiple contrasts acquired at a reasonably high resolution (1-mm isotropic voxel T1-weighted and FLAIR contrasts) using 3T scanners. These contrasts, coregistered with T2-weighted and proton-density-weighted contrasts, may provide cortical lesion counts closer in number to those provided by 7T MRI scans. Because 7T scanners are not widely available for clinical or extensive research studies, I considered it important to perform a more in-depth assessment of multicontrast 3T reading protocols as tools to detect cortical lesions.